GovChime
UEI: H7J3BSF8YU13 • CAGE: 54YN2

BIOREP TECHNOLOGIES, INC. (FL)

Registration and award facts

SAM.gov registration as of

Net obligations since FY2017
$493.54K
$493,536under this UEI
FY2026 obligations
$0
Provisional
Awards and orders
7
with positive net obligations
Latest action
Oct 4, 2024
SAM.gov registration
Active
Registration expiration date Aug 10, 2027

Registration

Entity structure
Corporate Entity (Not Tax Exempt)
Business start date
Nov 21, 1994 (31 years)
Location
Miami Lakes, FL
State of incorporation
Florida
Purpose of registration
All Awards
Website
biorep.com

† FY2026 obligations (provisional; DoD awards signed after Jul 30, 2026 are not yet public).

Source: SAM.gov entity registration and FPDS contract actions recorded under UEI H7J3BSF8YU13. GovChime does not check exclusions.

Performance

Net obligations recorded under this UEI since FY2017. Top lists show the largest five by share of this vendor's net obligations; the shares do not sum to 100%.

Net obligations by fiscal year of action

  • FY2024: $32,338
  • FY2023: $10,000
  • FY2022: $49,686
  • FY2021: $279,440
  • FY2020: $65,209
  • FY2017: $56,863

Total across 6 fiscal years: $493,536

Top awarding agencies

Top awarding sub-agencies

Top NAICS by obligations

Top product and service codes by obligations

  • 6640Laboratory equipment and supplies$451,198, 91.4%
  • 6515Medical and surgical instruments, equipment, and supplies$32,338, 6.6%
  • J066Maint/repair/rebuild of equipment- instruments and laboratory equipment$10,000, 2.0%

Capabilities

NAICS codes

Small: small business for that NAICS, self-certified in SAM.gov registration.

SBA certifications

No certification in the SBA profile data.

Product and service codes (PSC)

  • 6515MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES
  • 6640LABORATORY EQUIPMENT AND SUPPLIES

Capabilities & Services

Medical Device
Islet research
islet cell function
Islet GSIS
Dynamic GSIS
Glucose Stimulated Insulin Secretion
Beta Derived Stem Cell
Diabetes Research
ISO 13485 Certified
Perifusion
Perfusion
Surgical Device
Stem Cell Research
FDA Registered

Contracts

Latest awards and orders

  1. 36C24924P1249Purchase orderDepartment of Veterans AffairsLatest action
  2. 75N94023P00042Purchase orderDepartment of Health and Human ServicesNational Institutes of HealthLatest action
  3. HHSN275201700764PPurchase orderDepartment of Health and Human ServicesNational Institutes of HealthLatest action
  4. 36C25222P0150Purchase orderDepartment of Veterans AffairsLatest action
  5. 75N94021P00460Purchase orderDepartment of Health and Human ServicesNational Institutes of HealthLatest action
  6. 36C26021P0082Purchase orderDepartment of Veterans AffairsLatest action
  7. 36C25620P0654Purchase orderDepartment of Veterans AffairsLatest action

Contact Info

As of . Source: SAM.gov Points of Contact.

SAM.gov registration for BIOREP TECHNOLOGIES, INC. lists a physical address and a separate mailing address, along with 6 verified points of contact. Past Performance contacts are the recommended outreach channel for due-diligence references; Government Business contacts handle procurement-facing correspondence.

Source: SAM.gov entity registration. Contacts displaying numeric or placeholder names have been filtered (defense-in-depth).

Physical Address

15804 NW 57TH AVE

MIAMI LAKES, FL, 33014

USA

Mailing Address

15804 NW 57TH AVE

MIAMI LAKES, FL, 33014

USA

Government Business Contact

Felipe Echeverri

CEO

15804 NW 57TH AVE

MIAMI LAKES, FL, 33014

USA

Electronic Business Contact

Felipe Echeverri

CEO

15804 NW 57TH AVE

MIAMI LAKES, FL, 33014

USA

Past Performance Contact

Felipe Echeverri

CEO

15804 NW 57TH AVE

MIAMI LAKES, FL, 33014

USA

Government Business Alternate Contact

Felipe Echeverri

CEO

15804 NW 57TH AVE

MIAMI LAKES, FL, 33014

USA

Electronic Business Alternate Contact

Felipe Echeverri

CEO

15804 NW 57TH AVE

MIAMI LAKES, FL, 33014

USA

Past Performance Alternate Contact

Felipe Echeverri

CEO

15804 NW 57TH AVE

MIAMI LAKES, FL, 33014

USA

Additional Details

As of . Source: SAM.gov Entity Registration.

BIOREP TECHNOLOGIES, INC. has no active federal suspension or debarment on record in SAM.gov. Current SAM.gov registration expires August 10, 2027.

Source: SAM.gov entity registration (FAR responses, registration status). Always verify active exclusions against the authoritative record on SAM.gov before contract award.

Compliance & Risk Assessment

Source: SAM.gov FAR responses

Suspension/Debarment Status

SAM.gov registration reports no active exclusion

Public Display

Entity information is publicly displayed

Disaster Relief Registry

Registered for disaster relief contracting

Bonding Information

No bonding information provided

EDI

Not declared in SAM.gov

Business Structure

Source: SAM.gov
Profit Structure:For Profit Organization
Organization:Subchapter S Corporation

Registration Details

Source: SAM.gov

Initial Registration

Jul 16, 2008

Last Update

Aug 10, 2026

Registration Activation

Active — Aug 10, 2026

Fiscal Year End

12/31

Country of Incorporation

USA

Congressional District

26